XML 20 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 26, 2019
Jun. 27, 2018
Cash flows from operating activities:    
Net income $ 49,729 $ 21,385
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 11,281 13,205
Operating (gains), losses and other charges, net (35,368) 822
Amortization of deferred financing costs 304 303
Gain on investments (106) 0
Gain on early extinguishments of debt and leases (83) (161)
Deferred income tax expense 4,944 2,896
Share-based compensation 4,966 2,561
Decrease (increase) in assets:    
Receivables 7,545 2,323
Inventories 646 38
Other current assets (4,748) (253)
Other assets 6,110 (445)
Increase (decrease) in liabilities:    
Accounts payable (2,190) (7,280)
Accrued salaries and vacations (4,597) (2,029)
Accrued taxes (952) 428
Other accrued liabilities (4,264) (6,352)
Other noncurrent liabilities (8,062) (1,345)
Net cash flows provided by operating activities 25,155 26,096
Cash flows from investing activities:    
Capital expenditures (6,777) (9,512)
Acquisition of restaurants and real estate (4,706) (10,416)
Deposits on acquisitions of real estate (4,320) 0
Proceeds from sales of restaurants, real estate and other assets 47,938 4
Investment purchases (1,300) 0
Collections on notes receivable 858 1,921
Issuance of notes receivable (718) (2,455)
Net cash flows provided by (used in) investing activities 30,975 (20,458)
Cash flows from financing activities:    
Revolver borrowings 66,500 66,500
Revolver payments (82,000) (43,500)
Long-term debt payments (1,547) (1,643)
Proceeds from exercise of stock options 550 1,013
Tax withholding on share-based payments (3,178) (1,696)
Purchase of treasury stock (37,266) (28,964)
Net bank overdrafts (1,923) 1,419
Net cash flows used in financing activities (58,864) (6,871)
Decrease in cash and cash equivalents (2,734) (1,233)
Cash and cash equivalents at beginning of period 5,026 4,983
Cash and cash equivalents at end of period $ 2,292 $ 3,750